Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute
Yardley, Denise A.; Bosserman, Linda D.; O’Shaughnessy, Joyce A.; Harwin, William N.; Morgan, Susan K.; Priego, Victor M.; Peacock, Nancy W.; Bass, J. David; Burris III, Howard A.; Hainsworth, John D.
- 期刊名称Breast Cancer Research and Treatment
- 作者Yardley, Denise A.; Bosserman, Linda D.; O’Shaughnessy, Joyce A.; Harwin, William N.; Morgan, Susan K.; Priego, Victor M.; Peacock, Nancy W.; Bass, J. David; Burris III, Howard A.; Hainsworth, John D.
- 卷第154卷
- 期第1期
- 印刷ISSN0167-6806
- 电子ISSN1573-7217
- 文件大小690.51KB
- 发表时间2015-11-12
- DOI10.1007/s10549-015-3599-5
- 页码89-97